Solid Biosciences Inc.
SLDB
$5.20
-$0.19-3.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 25.95% | 25.95% | 25.95% | 259.62% | 116.92% |
| Gross Profit | -25.95% | -25.95% | -25.95% | -259.62% | -116.92% |
| SG&A Expenses | 19.83% | 21.54% | 19.98% | 30.80% | 21.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.78% | 44.15% | 24.36% | 5.66% | -3.92% |
| Operating Income | -56.78% | -44.15% | -24.36% | -5.66% | 3.92% |
| Income Before Tax | -69.90% | -54.77% | -29.87% | -12.78% | -0.48% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -69.90% | -54.77% | -29.87% | -12.78% | -0.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -69.90% | -54.77% | -29.87% | -12.78% | -0.48% |
| EBIT | -56.78% | -44.15% | -24.36% | -5.66% | 3.92% |
| EBITDA | -58.84% | -44.85% | -25.10% | -6.53% | 3.63% |
| EPS Basic | 15.20% | 24.08% | 37.27% | 40.94% | 51.59% |
| Normalized Basic EPS | 15.20% | 24.14% | 37.31% | 47.78% | 55.95% |
| EPS Diluted | 15.20% | 24.08% | 37.31% | 40.98% | 51.62% |
| Normalized Diluted EPS | 15.20% | 24.14% | 37.31% | 47.78% | 55.95% |
| Average Basic Shares Outstanding | 104.91% | 95.11% | 105.27% | 98.89% | 104.96% |
| Average Diluted Shares Outstanding | 104.91% | 95.11% | 105.27% | 98.89% | 104.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |